Results 191 to 200 of about 17,587 (206)
Some of the next articles are maybe not open access.

Chemotherapeutic options for the treatment of human trichomoniasis

International Journal of Antimicrobial Agents, 2019
Trichomonas vaginalis is the causative agent of the most common non-viral sexually transmitted disease worldwide. The infection may be associated with severe complications, including infertility, preterm labour, cancer and an increased risk of human ...
Ursula Fürnkranz   +2 more
exaly   +2 more sources

Developing a new drug against trichomoniasis, new inhibitory compounds of the protein triosephosphate isomerase.

Parasitology international, 2020
Trichomonas vaginalis is the protozoan parasite responsible for the most prevalent, non-viral, sexually transmitted disease, which affects millions of people around the world.
J. L. Vique‐Sánchez   +3 more
semanticscholar   +1 more source

Management of Resistant Trichomoniasis

Current Infectious Disease Reports, 2019
Paul Nyirjesy
exaly   +2 more sources

Antitrichomonal activity of metronidazole-loaded lactoferrin nanoparticles in pigeon trichomoniasis

Parasitology Research, 2021
M. A. Tabari   +6 more
semanticscholar   +1 more source

Humoral and T cell–mediated immune response against trichomoniasis

Parasite immunology (Print), 2018
M. Nemati   +4 more
semanticscholar   +1 more source

Challenges and Persistent Questions in the Treatment of Trichomoniasis

Current Topics in Medicinal Chemistry, 2017
Tiana Tasca   +2 more
exaly  

Single-dose versus multidose metronidazole for the treatment of vaginal trichomoniasis: A meta-analysis

European Journal of Obstetrics, Gynecology and Reproductive Biology, 2020
Shi-Yuan Wei   +2 more
exaly  

Home - About - Disclaimer - Privacy